# Retail COVID-19 Study

> **NCT06761612** · — · ACTIVE_NOT_RECRUITING · sponsor: **Biomedical Advanced Research and Development Authority** · enrollment: 2660 (estimated)

## Conditions studied

- COVID - 19

## Interventions

- **BIOLOGICAL:** FDA approved mRNA vaccines

## Key facts

- **NCT ID:** NCT06761612
- **Lead sponsor:** Biomedical Advanced Research and Development Authority
- **Sponsor class:** FED
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-10-19
- **Primary completion:** 2026-04
- **Final completion:** 2026-05
- **Target enrollment:** 2660 (ESTIMATED)
- **Last updated:** 2025-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06761612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06761612, "Retail COVID-19 Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06761612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
